Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr Red is an Australian-based nutraceutical company that specializes in the research, development, and production of functional foods and beverages with high antioxidant properties. The company is best known for its proprietary Cellular Fraction Line (CFL) technology, which allows for the extraction of bioactive compounds from plant sources such as red wine grapes, turmeric, and ginger without the use of harsh chemicals. Their product range, which includes the signature Dr Red Punch and various concentrated extracts, is marketed for its anti-inflammatory benefits and support for general health. Dr Red focuses on the food as medicine philosophy, bridging the gap between traditional nutrition and biotechnology. The company operates its own manufacturing facilities in Queensland, Australia, ensuring quality control from extraction to finished product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Red Nutraceuticals.